The Surgical Management of Benign Neoplasms of the Small Intestine

Abstract

Small intestinal benign tumours are uncommon clinical conditions that frequently go asymptomatic for the entirety of a patient's life. The small bowel contains only a tiny number of primary neoplasms, while making up most of the surface area and most of the length of the gastrointestinal (GI) tract. There are the following subtypes: Hyperplastic polyps, hamartomas, adenoma, stromal tumours, lipomas, hemangiomas, and   patients who have Peutz-Jeghers syndrome. Clinically, speaking, benign small-bowel lesions are distinguished by the absence of distinguishing symptoms. Up to the proximal duodenum lesions can be diagnosed with enteroscopy. Push or double-balloon enteroscopy methods can be used to reach the GI tract beyond the ligament of Treitz. The sole method of treatment for those who have small bowel adenocarcinoma is surgery. The majority of research state that between 40 and 65 percent of patients lend themselves to curative resection. The utilisation of laparoscopic surgery (LS) for small intestine gastrointestinal stromal tumours (GISTs) has expanded with the introduction of LS. There is currently no evidence to suggest a statistically significant difference between LS and open surgery in terms of prognosis. This review aims to summarize evaluation and management of benign neoplasms of the small intestine.